Leerink Partnrs Issues Optimistic Outlook for UTHR Earnings
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Leerink Partnrs raised their Q3 2025 earnings per share (EPS) estimates for United Therapeutics in a note issued to investors on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz now forecasts that the biotechnology company will post earnings per share of $8.50 for the quarter, up from […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Leerink Partnrs raised their Q3 2025 earnings per share (EPS) estimates for United Therapeutics in a note issued to investors on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz now forecasts that the biotechnology company will post earnings per share of $8.50 for the quarter, up from […]
